Latus Bio
Latus Bio is a clinical-stage gene therapy company engineering novel adeno-associated virus (AAV) capsids to deliver genetic medicines to precise cell types in the central nervous system and peripheral tissues. The company screens tens of millions of novel capsid variants to build a proprietary database of tissue-targeting "delivery zip codes," pairing engineered capsids with optimized routes of administration so therapeutics reach the intended tissue at a fraction of conventional doses and with minimal off-tissue biodistribution. Its lead programs are LTS-201 for Huntington's disease (AAV.DB-3 capsid) and LTS-101 for CLN2 disease, spanning CNS and ocular delivery (AAV.Ep+ capsid). Latus Bio operates offices and laboratories in Philadelphia, Pennsylvania and in Boston's Seaport district, and is backed by DCVC Bio, 8VC, BioAdvance, Samsung Venture Investment, and KDB. Latus Bio is catalogued in the API Evangelist network as a life-sciences company; it publishes no public developer platform, API, or SDK surface at this time.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Latus Bio the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Latus Bio scores 13.9/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Latus Bio
Each block below is one kind of artifact we hold for Latus Bio. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Latus Bio — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Other 2
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/latus-bio · machine-readable index on apis.io